| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1396176 | European Journal of Medicinal Chemistry | 2011 | 9 Pages |
The aim of the present study was to develop a colon targeted delivery system for metronidazole using polymeric prodrug formulation. Two chitosan amide conjugates of metronidazole were prepared by using two different spacers to covalently link the drug to the amino group of the chitosan glucosamine units. Glutaric and succinic hemiesters of metronidazole were thus prepared and then coupled to chitosan to obtain metronidazole-glutaryl- and metronidazole-succinyl-chitosan conjugates. Polymeric prodrugs were characterized by solid state NMR method, namely carbon 13 cross polarization magic angle spinning (13C NMR CPMAS). Prodrug stability study was carried out in acid (pH = 1.2) and in alkaline (pH = 7.4) buffers in a thermostatic bath at 37 °C. Drug release from the two prodrugs was studied by incubating each of them with 10% w/v cecal and colonic content of rats. Obtained results showed that both prodrugs were adequately stable in acid environment, while the succinyl conjugate was more stable than the glutaryl one in alkaline buffer. Both the prodrugs released the drug in cecal and colonic content, showing that the two systems could serve as colon specific delivery systems of metronidazole.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slideHighlights► Two chitosan amide conjugates of metronidazole were prepared as colon specific delivery systems. ► In vitro prodrug stability and ex vivo drug release studies were performed. ► Metronidazole was selectively released in the content of cecum and colon of rats.
